 |
市場調查報告書
商品編碼
1158938
再生障礙性貧血治療的全球市場調查報告-產業分析，規模，佔有率，成長，趨勢，2022年～2028年前的預測Global Aplastic Anemia Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028 |
||||||
Value Market Research深入調查再生障礙性貧血治療的全球市場，並預測未來幾年行業將出現顯著增長。本研究報告提供全球再生障礙性貧血治療市場相關之完全產業分析，提供市場規模、市場佔有率、增長趨勢、2023年至2028年的預測等。該報告以詳細的市場介紹和突出報告關鍵增長數據的執行摘要為首。接續的章節討論市場價值鏈、波特五力模型和市場吸引力分析。同時還設立關於COVID-19影響分析的獨立章節，以了解市場如何應對疫情。
本報告的市場動態部分詳細介紹了當前的市場推動因素/阻礙、課題/風險和未來機遇。本節對企業戰略家和新產品開發部門非常有用。再生障礙性貧血治療全球市場調查將市場細分化，並根據收益和/或銷售額的視點提供市場規模。該數據地區細分，同時國家/地區細分。數據是通過深入的初級訪談和世界各地的行業專家收集而來。詳細的調查方法可以在樣本報告中找到。這些市場預測受到最新的社會、政治和經濟變化以及影響該再生障礙性貧血治療市場的當前市場動態所影響。
再生障礙性貧血治療市場報告的子章節提供市場競爭力調查，提供一些領先的市場參與者/製造商簡介。這些章節涵括可深入了解競爭對手的產品線、財務狀況、最新發展以及在行業中擁有最高市場佔有率公司所需的豐富資訊。
本報告的觀察對象國家如下列。
北美。北美:美國，加拿大，墨西哥
歐洲英國，德國，法國，義大利，俄羅斯，西班牙，其他的歐洲地區
亞太地區。中國，印度，日本，韓國，澳洲，其他APAC的各國
南美巴西，阿根廷，秘魯，智利及其他的南美各國
中東·非洲地區沙烏地阿拉伯, UAE,以色列,南非
本報告的市場區隔如下列。
各治療類型
骨髓輸血或幹細胞療法
輸血
藥物療法(Alemtuzumab，抗胸腺細胞球朊，烷化劑，免疫抑制劑，其他)
各疾病類型
後天性再生障礙性貧血
遺傳性再生障礙性貧血
各給藥途徑
靜脈注射(IV)
口服
各銷售管道
零售店
醫院內藥局
線上藥局
目錄
第1章 序文
- 本報告的內容
- 目的
- 主要讀者
- 獨特的銷售主張(USP)及提供服務
- 調查範圍
- 調查手法
- 市場調查流程
- 市場調查手法
第2章 摘要整理
- 市場概況
- 全球市場概述
第3章 再生障礙性貧血治療- 產業分析
- 簡介- 市場動態
- 推動市場要素
- 阻礙市場要素
- 商機
- 產業趨勢
- 波特的五力分析
- 市場魅力分析
- 各治療類型
- 各疾病類型
- 各給藥途徑
- 各銷售管道
- 各地區
第4章 價值鏈分析
- 價值鏈分析
- 原料的分析
- 原料的清單
- 原料的製造原清單
- 主要原料的價格趨勢
- 潛在的買主清單
- 銷售管道
- 直銷
- 間接行銷
- 行銷流通管道的新興國家市場開拓趨勢
第5章 COVID-19發生的影響分析
- COVID-19發生影響分析
- 對生產的直接性影響
- 供應鏈與市場的混亂
- 對企業及金融市場的財務性影響
- COVID-19生產，進口，出口，各需求的影響分析
- 市場COVID-19發生前/發生後
- 冠狀病毒(COVID-19)流行的影響預測
- COVID-19:微觀和宏觀的要素分析
第6章 再生障礙性貧血治療的全球市場分析:各治療類型
- 各治療類型概要
- 實際成果資料與預測資料
- 各治療類型分析
- 骨髓輸血或幹細胞療法的各地區市場
- 輸血療法的各地區市場
- 藥物療法的各地區市場
第7章 再生障礙性貧血治療的全球市場分析:各疾病類型
- 各疾病類型概要
- 實際成果資料與預測資料
- 各疾病類型分析
- 後天性再生障礙性貧血的各地區市場
- 遺傳性再生障礙性貧血的各地區市場概要
第8章 再生障礙性貧血治療的全球市場分析:各給藥途徑
- 各給藥途徑概要
- 實際成果資料與預測資料
- 各給藥途徑分析
- 靜脈注射(IV)市場:各地區
- 各地區口服給藥市場
第9章 再生障礙性貧血治療的全球市場分析:各流通管道
- 各流通管道概要
- 實際成果資料與預測資料
- 各流通管道分析
- 零售藥局的各地區市場
- 醫院內藥局的各地區市場
- 線上藥局的各地區市場
第10章 再生障礙性貧血治療的全球市場分析:各地區
- 各地區的展望
- 簡介
- 北美
- 概要，過去實際成果與預測資料
- 北美:各市場區隔
- 北美各國資料
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 概要，過去實際成果與預測資料
- 歐洲:各市場區隔
- 歐洲的各國資料
- 英國
- 法國
- 德國
- 義大利
- 俄羅斯
- 其他的歐洲地區
- 亞太地區
- 概要，過去實際成果與預測資料
- 亞太地區:各市場區隔
- 亞太地區各國資料
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 其他亞太地區
- 南美
- 概要，過去實際成果與預測資料
- 南美:各市場區隔
- 南美:各國資料
- 巴西
- 阿根廷
- 秘魯
- 智利
- 其他的南美地區
- 中東·非洲地區
- 概要，過去實際成果與預測資料
- 中東·非洲:各市場區隔
- 中東·非洲地區各國資料
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 其他的中東·非洲地區
第11章 再生障礙性貧血治療企業的競爭情形
- 再生障礙性貧血治療市場競爭
- 聯盟·合作·協定
- 合併·收購
- 新產品上市
- 其他的開發
第12章 企業簡介
- 企業佔有率分析
- 市場集中度
- Pfizer Inc.
- 企業概要
- 產品介紹
- 最近的開發情形
- Novartis Pharmaceuticals Corporation
- 公司概要
- 產品介紹
- 最近的開發情形
- Amgen Inc.
- 公司概要
- 產品資訊
- 最近的開發情形
- GlaxoSmithKline plc
- 公司概要
- 產品資訊
- 最近的開發情形
- Kyowa Kirin Co., Ltd.
- 公司概要
- 產品資訊
- 最近的開發情形
- Jiangsu Hengrui Medicine Co., Ltd.
- 公司概要
- 產品資訊
- 最新資訊
在公司簡介中，財務細節和最近的發展基於可取得的現有信息，可能不包含非上市公司。
Value Market Research deeply researched the Global Aplastic Anemia Treatment Market to foresee a significant growth in the industry over the upcoming years. The global aplastic anemia treatment market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.
The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global aplastic anemia treatment market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this aplastic anemia treatment market.
The next sections of the aplastic anemia treatment market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.
Countries Covered in the report are as below:
North America: United States, Canada, and Mexico
Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC
Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America
Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa
Market Segmentation in the report is as below:
By Treatment Type
Bone Marrow Transfusion or Stem Cell Therapy
Blood Transfusion
Drug Therapy (Alemtuzumab, Antithymocyte Globulin, Alkylating Agents, Immunosuppressant, Others)
By Disease Type
Acquired Aplastic Anemia
Inherited Aplastic Anemia
By Route of Administration
Intravenous (IV)
Oral
By Distribution Channel
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. APLASTIC ANEMIA TREATMENT - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 By Treatment Type
- 3.7.2 By Disease Type
- 3.7.3 By Route of Administration
- 3.7.4 By Distribution Channel
- 3.7.5 By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5. IMPACT ANALYSIS OF COVID-19 OUTBREAK
- 5.1. Impact Analysis of Covid-19 Outbreak
- 5.1.1. Direct Impact on Production
- 5.1.2. Supply Chain and Market Disruption
- 5.1.3. Financial Impact on Firms and Financial Markets
- 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
- 5.3. Market: Pre V/S Post COVID-19
- 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
- 5.5. COVID-19: Micro and Macro Factor Analysis
6. GLOBAL APLASTIC ANEMIA TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
- 6.1 Overview by Treatment Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Treatment Type
- 6.4 Bone Marrow Transfusion or Stem Cell Therapy Market by Regions
- 6.5 Blood Transfusion Market by Regions
- 6.6 Drug Therapy Market by Regions
7. GLOBAL APLASTIC ANEMIA TREATMENT MARKET ANALYSIS BY DISEASE TYPE
- 7.1 Overview by Disease Type
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Disease Type
- 7.4 Acquired Aplastic Anemia Market by Regions
- 7.5 Inherited Aplastic Anemia Market by Regions
8. GLOBAL APLASTIC ANEMIA TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
- 8.1 Overview by Route of Administration
- 8.2 Historical and Forecast Data
- 8.3 Analysis by Route of Administration
- 8.4 Intravenous (IV) Market by Regions
- 8.5 Oral Market by Regions
9. GLOBAL APLASTIC ANEMIA TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL
- 9.1 Overview by Distribution Channel
- 9.2 Historical and Forecast Data
- 9.3 Analysis by Distribution Channel
- 9.4 Retail Pharmacies Market by Regions
- 9.5 Hospital Pharmacies Market by Regions
- 9.6 Online Pharmacies Market by Regions
10. GLOBAL APLASTIC ANEMIA TREATMENT MARKET ANALYSIS BY GEOGRAPHY
- 10.1. Regional Outlook
- 10.2. Introduction
- 10.3. North America
- 10.3.1. Overview, Historic and Forecast Data
- 10.3.2. North America By Segment
- 10.3.3. North America By Country
- 10.3.4. United State
- 10.3.5. Canada
- 10.3.6. Mexico
- 10.4. Europe
- 10.4.1. Overview, Historic and Forecast Data
- 10.4.2. Europe by Segment
- 10.4.3. Europe by Country
- 10.4.4. United Kingdom
- 10.4.5. France
- 10.4.6. Germany
- 10.4.7. Italy
- 10.4.8. Russia
- 10.4.9. Rest Of Europe
- 10.5. Asia Pacific
- 10.5.1. Overview, Historic and Forecast Data
- 10.5.2. Asia Pacific by Segment
- 10.5.3. Asia Pacific by Country
- 10.5.4. China
- 10.5.5. India
- 10.5.6. Japan
- 10.5.7. South Korea
- 10.5.8. Australia
- 10.5.9. Rest Of Asia Pacific
- 10.6. Latin America
- 10.6.1. Overview, Historic and Forecast Data
- 10.6.2. Latin America by Segment
- 10.6.3. Latin America by Country
- 10.6.4. Brazil
- 10.6.5. Argentina
- 10.6.6. Peru
- 10.6.7. Chile
- 10.6.8. Rest of Latin America
- 10.7. Middle East & Africa
- 10.7.1. Overview, Historic and Forecast Data
- 10.7.2. Middle East & Africa by Segment
- 10.7.3. Middle East & Africa by Country
- 10.7.4. Saudi Arabia
- 10.7.5. UAE
- 10.7.6. Israel
- 10.7.7. South Africa
- 10.7.8. Rest Of Middle East And Africa
11. COMPETITIVE LANDSCAPE OF THE APLASTIC ANEMIA TREATMENT COMPANIES
- 11.1. Aplastic Anemia Treatment Market Competition
- 11.2. Partnership/Collaboration/Agreement
- 11.3. Merger And Acquisitions
- 11.4. New Product Launch
- 11.5. Other Developments
12. COMPANY PROFILES OF APLASTIC ANEMIA TREATMENT INDUSTRY
- 12.1. Company Share Analysis
- 12.2. Market Concentration Rate
- 12.3. Pfizer Inc.
- 12.3.1. Company Overview
- 12.3.2. Financials
- 12.3.3. Products
- 12.3.4. Recent Developments
- 12.4. Novartis Pharmaceuticals Corporation
- 12.4.1. Company Overview
- 12.4.2. Financials
- 12.4.3. Products
- 12.4.4. Recent Developments
- 12.5. Amgen Inc.
- 12.5.1. Company Overview
- 12.5.2. Financials
- 12.5.3. Products
- 12.5.4. Recent Developments
- 12.6. GlaxoSmithKline plc
- 12.6.1. Company Overview
- 12.6.2. Financials
- 12.6.3. Products
- 12.6.4. Recent Developments
- 12.7. Kyowa Kirin Co., Ltd.
- 12.7.1. Company Overview
- 12.7.2. Financials
- 12.7.3. Products
- 12.7.4. Recent Developments
- 12.8. Jiangsu Hengrui Medicine Co., Ltd.
- 12.8.1. Company Overview
- 12.8.2. Financials
- 12.8.3. Products
- 12.8.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Treatment Type (USD MN)
- Bone Marrow Transfusion or Stem Cell Therapy Market by Geography (USD MN)
- Blood Transfusion Market by Geography (USD MN)
- Drug Therapy Market by Geography (USD MN)
- Analysis Market by Disease Type (USD MN)
- Acquired Aplastic Anemia Market by Geography (USD MN)
- Inherited Aplastic Anemia Market by Geography (USD MN)
- Analysis by Route of Administration (USD MN)
- Intravenous (IV) Market by Geography (USD MN)
- Oral Market by Geography (USD MN)
- Analysis by Distribution Channel (USD MN)
- Retail Pharmacies Market by Geography (USD MN)
- Hospital Pharmacies Market by Geography (USD MN)
- Online Pharmacies Market by Geography (USD MN)
- Global Aplastic Anemia Treatment Market by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
LIST OF FIGURES
- Research Scope of Aplastic Anemia Treatment Report
- Market Research Process
- Market Research Methodology
- Global Aplastic Anemia Treatment Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Treatment Type
- Market Attractiveness Analysis by Disease Type
- Market Attractiveness Analysis by Route of Administration
- Market Attractiveness Analysis by Distribution Channel
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Treatment Type (USD MN)
- Bone Marrow Transfusion or Stem Cell Therapy Market by Geography (USD MN)
- Blood Transfusion Market by Geography (USD MN)
- Drug Therapy Market by Geography (USD MN)
- Global Market Analysis by Disease Type (USD MN)
- Acquired Aplastic Anemia Market by Geography (USD MN)
- Inherited Aplastic Anemia Market by Geography (USD MN)
- Global Market Analysis by Route of Administration (USD MN)
- Intravenous (IV) Market by Geography (USD MN)
- Oral Market by Geography (USD MN)
- Global Market Analysis by Distribution Channel (USD MN)
- Retail Pharmacies Market by Geography (USD MN)
- Hospital Pharmacies Market by Geography (USD MN)
- Online Pharmacies Market by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Company Market Share Analysis
- Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
